awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37486753-0FBD0E26-5429-44F1-88E7-B389B7B3B5D2
Q37486753-0FBD0E26-5429-44F1-88E7-B389B7B3B5D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37486753-0FBD0E26-5429-44F1-88E7-B389B7B3B5D2
Current status of cediranib: the rapid development of a novel anti-angiogenic therapy.
P2860
Q37486753-0FBD0E26-5429-44F1-88E7-B389B7B3B5D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37486753-0FBD0E26-5429-44F1-88E7-B389B7B3B5D2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e3838e232590a0a64f0c9224564847d5919d3be2
P2860
Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast canc